Moderna

Open: 122.5 Close: 122.11 Change: -0.39

You're running out of time to find out about Moderna Company Inc using an AI.

How much time have you spent trying to decide whether investing in Moderna? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, CEO, …

Concept Map

Semantic Network

Stock Summary

Moderna, Inc. discovers, develops, and commercializes messenger RNA therapeutics and vaccines. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV.

Today's Summary

Moderna (MRNA) closed at $123, marking a +1.93% move from the previous day. Bernie Sanders promised to grill Moderna CEO in a Senate hearing next month about plans to quadruple the price of its vaccine.

Today's News

Bernie Sanders promised to grill Moderna CEO in a Senate hearing next month about plans to quadruple the price of its COVID-19 vaccine. The pharmaceutical giant was widely denounced last month in the wake of reports it was considering jacking up the price. Moderna has begun testing other vaccines targeting breast, head and neck, and non-small cell lung cancer. CEO Stéphane Bancel believes those clinical results “will replicate in other cancer types” Moderna (NASDAQ: MRNA) closed at $123 in the latest trading session, marking a +1.93% move from the prior day. Moderna shares are up after the stock receives an upgrade from UBS.com. The projected fair value for Moderna is US$247 based on 2 Free Cash Flow. Moderna seeks FDA authorization for updated COVID-19 vaccine. Pending authorization, the updated shot would be available in time for the fall vaccination. Moderna Omicron Booster 6+ i FDA Emergency Use Authorization (EUA) for ages 18 and up. Pfizer-BioNTech (mRNA), Moderna and Johnson & Johnson (Vector vaccine) are currently in-stock. Moderna (MRNA) closed at $123, marking a +1.93% move from the previous day. Wall Street will be looking for positivity from Moderna as it approaches its next earnings report date. Moderna still has yet to undergo review before approval. CEO Stephane Bancel sold 10,000 shares of company stock, valued at $1.8 million in total. CEO still owns more than 21 million shares of Moderna stock. CEO Bancels Moderna holdings have dropped by billions. Moderna Inc. is developing mRNA-1608 Herpes Vaccine to reduce the burden of HSV lesions based on mRNA technology that offers potential advantages in efficacy, speed and production scalability and reliability.

Stock Profile

"Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts."

Keywords

Are looking for the most relevant information about Moderna? Investor spend a lot of time searching for information to make investment decisions in Moderna. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: Moderna, CEO, vaccine, share, stock, next, month, and the most common words in the summary are: moderna, vaccine, stock, market, covid19, mrna, price, . One of the sentences in the summary was: Moderna (MRNA) closed at $123, marking a +1.93% move from the previous day. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #moderna #vaccine #stock #market #covid19 #mrna #price.